Chronic myeloid leukaemia (CML) is a clonal stem cell disorder disease with the oncogenic fusion protein Bcr/Abl, which leads to the constitutive activation of Abl tyrosine kinase. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.